Sirtuin 3 improves fatty acid metabolism in response to high nonesterified fatty acids in calf hepatocytes by modulating gene expression.

Sirtuin 3 (SIRT3), a mitochondrial deacetylase, is a key regulator of energy metabolism in the liver. In nonruminants, the hepatic abundance of SIRT3 is decreased in individuals with nonalcoholic fatty liver diseases, and recovery of SIRT3 alleviates hepatic triacylglycerol (TG) deposition. However, the level of SIRT3 expression and its effects on lipid metabolism in dairy cows have not been characterized. Here we studied the hepatic expression of SIRT3 in cows with fatty liver and the role of SIRT3 in fatty acid metabolism in bovine hepatocytes. This in vivo study involved 10 healthy cows and 10 cows with fatty liver, from which we collected samples of liver tissue and blood. Primary hepatocytes were isolated from Holstein calves and treated with 0, 0.5, or 1.0 mM nonesterified fatty acids (NEFA) for 24 h or transinfected with SIRT3 overexpression adenovirus (Ad-SIRT3)/SIRT3-short interfering (si)RNA for 48 h. Cows with fatty liver displayed lower serum glucose concentrations but higher serum NEFA and β-hydroxybutyrate concentrations relative to healthy cows. Cows with fatty liver also had significant lower mRNA and protein abundance of hepatic SIRT3. Incubation of primary hepatocytes with NEFA reduced SIRT3 abundance in primary hepatocytes in a dose-dependent manner. Fatty acid (1 mM) treatment also markedly increased the abundance of acetyl-CoA carboxylase 1 (ACC1) and fatty acid synthase (FAS) but significantly decreased the abundance of carnitine palmitoyltransferase I (CPT1A), carnitine palmitoyltransferase II (CPT2), and acyl-CoA oxidase (ACO). Knockdown of SIRT3 by SIRT3-siRNA downregulated the mRNA abundance of CPT1A, CPT2, and ACO. In contrast, overexpression of SIRT3 by Ad-SIRT3 upregulated the mRNA abundance of CPT1A, CPT2, and ACO; downregulated the mRNA abundance of ACC1 and FAS; and consequently, decreased intracellular TG concentrations. Overexpression of SIRT3 ameliorated exogenous NEFA-induced TG accumulation by downregulating the abundance of ACC1 and FAS and upregulating the abundance of CPT1A, CPT2, and ACO in calf hepatocytes. Our data demonstrated that cows with fatty liver had lower hepatic SIRT3 contents, and an increase in SIRT3 abundance by overexpression mitigated TG deposition by modulating the expression of lipid metabolism genes in bovine hepatocytes. These data suggest a possible role of SIRT3 as a therapeutic target for fatty liver disease prevention in periparturient dairy cattle.

[1]  J. Loor,et al.  Perilipin 5 promotes hepatic steatosis in dairy cows through increasing lipid synthesis and decreasing very low density lipoprotein assembly. , 2019, Journal of dairy science.

[2]  J. Loor,et al.  Impaired hepatic autophagic activity in dairy cows with severe fatty liver is associated with inflammation and reduced liver function. , 2018, Journal of dairy science.

[3]  Guowen Liu,et al.  Adaptations of hepatic lipid metabolism and mitochondria in dairy cows with mild fatty liver. , 2018, Journal of dairy science.

[4]  D. Sinclair,et al.  Sirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases , 2018, Circulation research.

[5]  Hao Zhou,et al.  Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy , 2018, Redox biology.

[6]  L. Yao,et al.  Hepatic Sirt3 expression declines postpartum in dairy goats , 2018, Journal of Dairy Research.

[7]  M. Mazidi,et al.  The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis. , 2017, Atherosclerosis.

[8]  C. Deng,et al.  Emerging roles of SIRT1 in fatty liver diseases , 2017, International journal of biological sciences.

[9]  G. Korićanac,et al.  Obesity-driven prepartal hepatic lipid accumulation in dairy cows is associated with increased CD36 and SREBP-1 expression. , 2016, Research in veterinary science.

[10]  Weiqing Wang,et al.  Liraglutide ameliorates non‐alcoholic fatty liver disease by enhancing mitochondrial architecture and promoting autophagy through the SIRT1/SIRT3–FOXO3a pathway , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[11]  Yang Cheng,et al.  MicroRNA-421 induces hepatic mitochondrial dysfunction in non-alcoholic fatty liver disease mice by inhibiting sirtuin 3. , 2016, Biochemical and biophysical research communications.

[12]  Guowen Liu,et al.  SREBP-1c overactivates ROS-mediated hepatic NF-κB inflammatory pathway in dairy cows with fatty liver. , 2015, Cellular signalling.

[13]  Yu-cai Fu,et al.  Direct evidence of sirtuin downregulation in the liver of non-alcoholic fatty liver disease patients. , 2014, Annals of clinical and laboratory science.

[14]  H. Chen,et al.  Effects of nonesterified fatty acids on the synthesis and assembly of very low density lipoprotein in bovine hepatocytes in vitro. , 2014, Journal of dairy science.

[15]  Francisco M. Peixoto,et al.  Berberine reverts hepatic mitochondrial dysfunction in high-fat fed rats: a possible role for SirT3 activation. , 2013, Mitochondrion.

[16]  Xiongjie Shi,et al.  Activation of the Aryl Hydrocarbon Receptor Sensitizes Mice to Nonalcoholic Steatohepatitis by Deactivating Mitochondrial Sirtuin Deacetylase Sirt3 , 2013, Molecular and Cellular Biology.

[17]  Wei Yu,et al.  Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. , 2013, Molecular cell.

[18]  Alexander S. Banks,et al.  Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. , 2012, Physiological reviews.

[19]  Jian Ye,et al.  Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction , 2012, BMC Bioinformatics.

[20]  Johan Auwerx,et al.  Sirtuins as regulators of metabolism and healthspan , 2012, Nature Reviews Molecular Cell Biology.

[21]  Michael L. Blackburn,et al.  Maternal Obesity during Gestation Impairs Fatty Acid Oxidation and Mitochondrial SIRT3 Expression in Rat Offspring at Weaning , 2011, PloS one.

[22]  F. Villarroya,et al.  Bovine sirtuins: initial characterization and expression of sirtuins 1 and 3 in liver, muscle, and adipose tissue. , 2011, Journal of animal science.

[23]  C. Kahn,et al.  Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. , 2011, The Biochemical journal.

[24]  Robert V Farese,et al.  Sirt3 Regulates Fatty Acid Oxidation via Reversible Enzyme Deacetylation Hhs Public Access Supplementary Material , 2022 .

[25]  M. Doherty,et al.  Production diseases: a major health, welfare and economic problem on dairy farms. , 2008, Veterinary journal.

[26]  N. Friggens,et al.  On the use of milk composition measures to predict the energy balance of dairy cows. , 2007, Journal of dairy science.

[27]  M. Geelen,et al.  Postpartum fatty liver in high-producing dairy cows in practice and in animal studies. The connection with health, production and reproduction problems , 1997, Comparative Haematology International.

[28]  K. Ingvartsen.  Feeding- and management-related diseases in the transition cow , 2006 .

[29]  J W Young,et al.  Invited review: pathology, etiology, prevention, and treatment of fatty liver in dairy cows. , 2004, Journal of dairy science.

[30]  S. Motoyoshi,et al.  Preliminary Studies on Hepatic Carnitine Palmitoyltransferase in Dairy Cattle with or without Fatty Liver , 1999, Veterinary Research Communications.

[31]  Thomas B Farver,et al.  A Body Condition Scoring Chart for Holstein Dairy Cows , 1989 .